

HY-170922 · 50 mg
MedChemExpress · Cat: HY-170922
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/sars-cov-2-in-110.htmlDescription
SARS-CoV-2-IN-110 compound Bb1 is a SARS-CoV-2 inhibitor. SARS-CoV-2-IN-110 exhibits antiviral efficacy against SARS-CoV-2 with an EC50 of 1.10 ?M and significantly lower toxicity compared to Lapatinib HY-50898 . SARS-CoV-2-IN-110 inhibits SARS-CoV-2 with a CC50 of > 100 ?M, with a selectivity index SI of >91.







